|
General Information
|
|
|
Product
|
MAPK15 Peptide
|
|
Description
|
Antigenic Blocking Peptide Mitogen-activated protein kinase 15 Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 500-544 on human Mitogen-activated protein kinase 15.
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
1:500
|
|
Protein
|
|
Uniprot #
|
Q8TD08
|
|
Overview
|
In vitro, phosphorylates MBP.
|
|
Molecular Function
|
Kinase, Serine/threonine-protein kinase, Transferase
|
|
Subcellular Location
|
Extracellular region, intracellular, nucleus
|
|
Expression
|
Widely expressed with a maximal expression in lung and kidney.
|
|
Structure
|
The N-terminal region (1-20) is the minimal region necessary for ubiquitination and further proteasomal degradation.
The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.
|
|
Alternative Nomenclature
|
ERK7 antibody
ERK8 antibody
Extracellular regulated kinase 8 delta antibody
Extracellular signal-regulated kinase 7 antibody
MAP kinase 15 antibody
MAPK 15 antibody
Mitogen activated protein kinase 15 antibody
MK15_HUMAN antibody
|
| |
|
MAPK15 Antibody
MAPK15 Antibody BIOTIN
MAPK15 Antibody FITC
MAPK15 Positive Control
